Effects of the Intragastric Balloon MedSil (R) on Weight Loss, Fat Tissue, Lipid Metabolism, and Hormones Involved in Energy Balance

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61988987%3A17110%2F14%3AA1501A5P" target="_blank" >RIV/61988987:17110/14:A1501A5P - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Effects of the Intragastric Balloon MedSil (R) on Weight Loss, Fat Tissue, Lipid Metabolism, and Hormones Involved in Energy Balance

Popis výsledku v původním jazyce

Introduction: Obesity is associated with a number health-related problems as well as a shortened life span, treating obesity is an important clinical concern. In this study, we examined the effects of the intragastric balloon MedSil? on anthropometric measures and hormones associated with lipid and energy metabolism Methods: Twenty-two obese patients underwent insertion of the intragastric balloon MedSil? following a clinical exam, body composition scan and collection of blood samples. Results: Six months following insertion of the MedSil? balloon, we observed significant decreases in body weight, body mass index, and fat mass. Compared with baseline levels, ghrelin serum levels were increased significantly, while leptin, FGF21 and glycated hemoglobinlevels significantly decreased, 6 months after balloon insertion. Conclusion: The MedSil? intragastric balloon is a safe and effective treatment for morbid obesity, with positive effects on anthropometric measures and lipid metabolism.

Název v anglickém jazyce

Effects of the Intragastric Balloon MedSil (R) on Weight Loss, Fat Tissue, Lipid Metabolism, and Hormones Involved in Energy Balance

Popis výsledku anglicky

Introduction: Obesity is associated with a number health-related problems as well as a shortened life span, treating obesity is an important clinical concern. In this study, we examined the effects of the intragastric balloon MedSil? on anthropometric measures and hormones associated with lipid and energy metabolism Methods: Twenty-two obese patients underwent insertion of the intragastric balloon MedSil? following a clinical exam, body composition scan and collection of blood samples. Results: Six months following insertion of the MedSil? balloon, we observed significant decreases in body weight, body mass index, and fat mass. Compared with baseline levels, ghrelin serum levels were increased significantly, while leptin, FGF21 and glycated hemoglobinlevels significantly decreased, 6 months after balloon insertion. Conclusion: The MedSil? intragastric balloon is a safe and effective treatment for morbid obesity, with positive effects on anthropometric measures and lipid metabolism.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FB - Endokrinologie, diabetologie, metabolismus, výživa

OECD FORD obor

—

Projekt

—

Návaznosti

S - Specificky vyzkum na vysokych skolach

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

OBES SURG

ISSN

0960-8923

e-ISSN

—

Svazek periodika

24

Číslo periodika v rámci svazku

6

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

7

Strana od-do

909-915

Kód UT WoS článku

000336372300013

EID výsledku v databázi Scopus

—